Liu Zhuo, Ge Liyuan, Liu Lei, Zhao Xun, Chen Kewei, Li Yuxuan, Aili Abudureyimujiang, Lu Min, Pei Xinlong, Han Dengyang, Zhang Shudong, Ma Lulin
Department of Urology, Peking University Third Hospital, Beijing, China.
Department of Radiation Oncology, Peking University Third Hospital, Haidian District, Beijing, China.
Front Oncol. 2022 May 10;12:873729. doi: 10.3389/fonc.2022.873729. eCollection 2022.
This study aims to report the surgical management, complications, and outcomes for patients with retroperitoneal tumor and venous thrombus.
We retrospectively analyzed 19 cases of retroperitoneal tumor with venous tumor thrombus from August 2015 to March 2021. A new tumor thrombus PUTH-RT grading system was proposed on the basis of the characteristics of the surgical techniques.
Two cases of PUTH-RT-1a, two cases of PUTH-RT-1b, six cases of PUTH-RT-2, six cases of PUTH-RT-3, and three cases of PUTH-RT-4 were included. Surgeries were successfully performed in all 19 patients. Among them, five cases (26.3%) were operated a completely laparoscopic approach and 13 cases (68.4%) an open approach. One case (5.3%) was converted from laparoscopic to open approach. Five cases (26.3%) experienced postoperative complications. All patients were followed for a median of 14 months. Cancer-associated death occurred in three cases. Distant metastases occurred in seven cases.
We propose a new tumor thrombus grading system based on the anatomical characteristics of retroperitoneal tumors with venous tumor thrombus. Retroperitoneal tumor resection and removal of venous tumor thrombi are safe and effective for the treatment of such diseases.
本研究旨在报告腹膜后肿瘤合并静脉血栓患者的手术治疗、并发症及预后情况。
回顾性分析2015年8月至2021年3月期间19例腹膜后肿瘤合并静脉瘤栓的病例。基于手术技术特点,提出了一种新的肿瘤栓子PUTH-RT分级系统。
纳入PUTH-RT-1a级2例、PUTH-RT-1b级2例、PUTH-RT-2级6例、PUTH-RT-3级6例、PUTH-RT-4级3例。19例患者均成功实施手术。其中,5例(26.3%)采用完全腹腔镜手术方式,13例(68.4%)采用开放手术方式。1例(5.3%)由腹腔镜手术转为开放手术。5例(26.3%)出现术后并发症。所有患者中位随访14个月。3例发生癌症相关死亡。7例出现远处转移。
我们基于腹膜后肿瘤合并静脉瘤栓的解剖学特点提出了一种新的肿瘤栓子分级系统。腹膜后肿瘤切除及静脉瘤栓清除术治疗此类疾病安全有效。